A universal magnetic carrier for use in cancer prodrug therapy
Magnetic nanoparticles have attracted huge amounts of interest in the scientific and healthcare communities. Fe3O4 and γ-Fe2O3 are magnetic nanoparticles of particular interest in nanotherapeutics and have already been approved for use by the Medicines and Healthcare Products Regulatory Agency along...
| Main Author: | |
|---|---|
| Published: |
Bangor University
2015
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.698922 |